Immune-related adverse events among patients with early-stage triple-negative breast cancer treated with pembrolizumab plus chemotherapy: real-world data from the Neo-Real/GBECAM 0123 study
接受帕博利珠单抗联合化疗治疗的早期三阴性乳腺癌患者的免疫相关不良事件:来自 Neo-Real/GBECAM 0123 研究的真实世界数据
期刊:Breast
影响因子:7.9
doi:10.1016/j.breast.2025.104473
Andrade, Matheus de Oliveira; Gutierres, Isabella Gonçalves; Tavares, Monique Celeste; de Sousa, Isadora Martins; Balint, Flávia Cavalcanti; Marin Comini, Ana Carolina; Gouveia, Mariana Carvalho; Bines, José; Madasi, Fernanda; Ferreira, Rafael Dal Ponte; Rosa, Daniela Dornelles; Santos, Candice Lima; Assad-Suzuki, Daniele; de Souza, Zenaide Silva; de Araújo, Júlio Antônio Pereira; de Melo Gagliato, Débora; Dos Anjos, Carlos Henrique; Zucchetti, Bruna M; Ferrari, Anezka; de Brito, Mayana Lopes; Cangussu, Renata; Fernandes Monteiro, Maria Marcela; Hoff, Paulo M; Del Pilar Estevez-Diz, Maria; Testa, Laura; Barroso-Sousa, Romualdo; Bonadio, Renata Colombo